Home > Income Statement > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Revenue

    Back to Income Statement
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹581 Cr₹510 Cr₹472 Cr₹424 Cr₹386 Cr

What is the latest Revenue of LINCOLN PHARMACEUTICALS ?

The latest Revenue ratio of LINCOLN PHARMACEUTICALS is ₹581 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹581 Cr
Mar2023₹510 Cr
Mar2022₹472 Cr
Mar2021₹424 Cr
Mar2020₹386 Cr

How is Revenue of LINCOLN PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2024 ₹581 Cr
13.76
Mar2023 ₹510 Cr
8.09
Mar2022 ₹472 Cr
11.30
Mar2021 ₹424 Cr
9.75
Mar2020 ₹386 Cr -

Compare Revenue of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,569.8 Cr -3.8% 24.7% 31.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,838.0 Cr 1% 4.6% 47.5% Stock Analytics
DIVIS LABORATORIES ₹156,107.0 Cr 1% -3.2% 59.3% Stock Analytics
CIPLA ₹120,270.0 Cr -1.1% -0.3% 20.7% Stock Analytics
DR REDDYS LABORATORIES ₹113,077.0 Cr 2.2% 12.1% 21.6% Stock Analytics
ZYDUS LIFESCIENCES ₹96,553.2 Cr -2.7% 0.8% 43.8% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-3.8%

24.7%

31.4%

SENSEX

-2.1%

-2%

11.3%


You may also like the below Video Courses